Iodine deficiency and prevalence of nodular goitre in Ukraine




iodine deficiency, nodular goitre, epidemiology, review


More than one tenth of the world population is to some degree affected by goitre and most of these harbour nodules. The large differences in thyroid disease prevalence between populations may be caused by genetic and environmental factors. Among the latter, iodine deficiency seems by far to be the most important risk factor. Thus, nodular goitre is a condition predominantly seen in iodine deficient areas of the world. Large thyroid volumes and high frequencies of goitres have been reported in countries affected by iodine deficiency. In the present review, we evaluated prevalences of thyroid nodules in iodine-deficient countries. In 2016 in Ukraine the prevalence of nodular goiter was 707.8 per 100 thousand population, then after 5 years the figure slowly increased to 891.5 cases, respectively (+25.9 %). The existing high indices of newly diagnosed patients with nodular goitre in the country in 2016 were 71.9, and at the end of 2020 — 90.2 initially established cases per 100 thousand population, with a positive increase of +25.5 %. In the Whickham survey, 20 % of women and 5 % of men who had goitres in the initial survey showed no evidence of goitre in a follow-up survey. An average growth rate in the multinodular goitre of 5–20 % was reported in iodine-sufficient areas. On the basis of the results of the Framingham survey, the estimated lifetime risk for developing a nodule is 5–10 %. Thyroid nodule size can increase, decrease, or remain stable, and thyroid nodules may eventually also disappear over time. Solid nodules more frequently increase, whereas cystic nodules can shrink or disappear. If the goitre has been present for some time, autonomous function of the nodules and eventually hyperthyroidism develop. The rate of progression from euthyroidism to subclinical and overt hyperthyroidism is about 10 %.


Download data is not yet available.


Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015 Apr;3(4):286-295. doi:10.1016/S2213-8587(14)70225-6.

Gunnarsdottir I, Dahl L. Iodine intake in human nutrition: a systematic literature review. Food Nutr Res. 2012;56. doi:10.3402/fnr.v56i0.19731.

Kelley S. Endocrinology Update: Thyroid Disorders. FP Essent. 2016 Dec;451:11-16.

Jiang H, Tian Y, Yan W, et al. The Prevalence of Thyroid Nodules and an Analysis of Related Lifestyle Factors in Beijing Communities. Int J Environ Res Public Health. 2016 Apr 22;13(4):442. doi:10.3390/ijerph13040442.

Miccoli P, Minuto MN, Orlandini C, Galleri D, Massi M, Berti P. Ultrasonography estimated thyroid volume: a prospective study about its reliability. Thyroid. 2006 Jan;16(1):37-39. doi:10.1089/thy.2006.16.37.

Tonacchera M, Pinchera A, Vitti P. Assessment of nodular goitre. Best Pract Res Clin Endocrinol Metab. 2010 Feb;24(1):51-61. doi:10.1016/j.beem.2009.08.008.

Venkatesh N, Ho JT. Investigating thyroid nodules. Aust Prescr. 2021 Dec;44(6):200-204. doi:10.18773/austprescr.2021.055.

Lou X, Wang X, Wang Z, et al. The Effect of Iodine Status on the Risk of Thyroid Nodules: A Cross-Sectional Study in Zhejiang, China. Int J Endocrinol. 2020 Aug 18;2020:3760375. doi:10.1155/2020/3760375.

Knudsen N, Bülow I, Jorgensen T, Laurberg P, Ovesen L, Perrild H. Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf). 2000 Oct;53(4):479-485. doi:10.1046/j.1365-2265.2000.01121.x.

Niwattisaiwong S, Burman KD, Li-Ng M. Iodine deficiency: Clinical implications. Cleve Clin J Med. 2017 Mar;84(3):236-244. doi:10.3949/ccjm.84a.15053.

Levie D, Korevaar TIM, Bath SC, et al. Association of Maternal Iodine Status With Child IQ: A Meta-Analysis of Individual Participant Data. J Clin Endocrinol Metab. 2019 Dec 1;104(12):5957-5967. doi:10.1210/jc.2018-02559.

Tronko M, Mabuchi K, Bogdanova T, et al. Thyroid cancer in Ukraine after the Chernobyl accident (in the framework of the Ukraine-US Thyroid Project). J Radiol Prot. 2012 Mar;32(1):N65-69. doi:10.1088/0952-4746/32/1/N65.

Кravchenko VI. Chornobyl accident and iodine deficiency as risk factors of thyroid pathology in population of the affected regions of Ukraine. Mìžnarodnij endokrinologìčnij žurnal. 2016;(74):13-20. doi:10.22141/2224-0721.2.74.2016.70911. (in Ukrainian).

Kamyshna II, Pavlovich LB, Maslyanko VA, Chornenka ZhA. Epidemiological assessment of dymamics of the prevalence and incidence of the thyroid gland diseases in Ukraine and Chernivtsi region. Сlinical and Experimental Pathology. 2021;20(3):75-81. doi:10.24061/1727-4338. XX.3.77.2021.11. (in Ukrainian).

Tkachenko VI, Maksymets YaA, Vydyborets NV, Kovalenko OF. Analysis of the prevalence and morbidity of thyroid pathology among the populationof Kyiv region and Ukraine for 2007-2017. Mìžnarodnij endokrinologìčnij žurnal. 2018;14(3):272-277. doi:10.22141/2224-0721.14.3.2018.136426. (in Ukrainian).

Kravchenko VI, Andrusyshyna IM, Luzanchuk IA, Polumbryk MO, Tarashchenko YM. Association Between Thyroid Hormone Status and Trace Elements in Serum of Patients with Nodular Goiter. Biol Trace Elem Res. 2020 Aug;196(2):393-399. doi:10.1007/s12011-019-01943-9.

Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68. doi:10.1111/j.1365-2265.1995.tb01894.x.

Rallison ML, Dobyns BM, Meikle AW, Bishop M, Lyon JL, Stevens W. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults. Am J Med. 1991 Oct;91(4):363-370. doi:10.1016/0002-9343(91)90153-o.

Ghassi D, Donato A. Evaluation of the thyroid nodule. Postgrad Med J. 2009 Apr;85(1002):190-195. doi:10.1136/pgmj.2008.072140.

Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018 Mar 6;319(9):914-924. doi:10.1001/jama.2018.0898.

Hooft L, Hoekstra OS, Boers M, Van Tulder MW, Van Diest P, Lips P. Practice, efficacy, and costs of thyroid nodule evaluation: a retrospective study in a Dutch university hospital. Thyroid. 2004 Apr;14(4):287-293. doi:10.1089/105072504323030942.

Tamhane S, Gharib H. Thyroid nodule update on diagnosis and management. Clin Diabetes Endocrinol. 2016 Oct 3;2:17. doi:10.1186/s40842-016-0035-7.

Giassa Τ, Mamali I, Gaki Ε, et al. Iodine intake and chronic autoimmune thyroiditis: a comparative study between coastal and mainland regions in Greece. Hormones (Athens). 2018 Dec;17(4):565-571. doi:10.1007/s42000-018-0057-x.

Carlé A, Krejbjerg A, Laurberg P. Epidemiology of nodular goitre. Influence of iodine intake. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):465-479. doi:10.1016/j.beem.2014.01.001.

Struve C, Hinrichs J. Thyroid gland volumes and the incidence of focal changes in euthyroid men and women in various age groups. Dtsch Med Wochenschr. 1989 Feb 24;114(8):283-287. doi:10.1055/s-2008-1066589. (in German).

Chew CR, Lam T, Chan STF, Chin-Lenn L. Systematic differences between ultrasound and pathological evaluation of thyroid nodules: a method comparison study. ANZ J Surg. 2018 May;88(5):464-467. doi:10.1111/ans.14045.

Wu MH, Chen KY, Chen A, Chen CN. Differences in the ultrasonographic appearance of thyroid nodules after radiofrequency ablation. Clin Endocrinol (Oxf). 2021 Sep;95(3):489-497. doi:10.1111/cen.14480.

Koh J, Lee E, Han K, et al. Diagnosis of thyroid nodules on ultrasonography by a deep convolutional neural network. Sci Rep. 2020 Sep 17;10(1):15245. doi:10.1038/s41598-020-72270-6.

Stark DD, Clark OH, Gooding GA, Moss AA. High-resolution ultrasonography and computed tomography of thyroid lesions in patients with hyperparathyroidism. Surgery. 1983 Dec;94(6):863-868.

Rezzonico J, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid. 2008 Apr;18(4):461-464. doi:10.1089/thy.2007.0223.

Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol. 2009 Oct;161(4):599-605. doi:10.1530/EJE-09-0410.

Anil C, Akkurt A, Ayturk S, Kut A, Gursoy A. Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism. 2013 Jul;62(7):970-975. doi:10.1016/j.metabol.2013.01.009.

Rezzónico J, Rezzónico M, Pusiol E, Pitoia F, Niepomniszcze H. Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord. 2011 Feb;9(1):69-75. doi:10.1089/met.2010.0026.

Ittermann T, Markus MR, Schipf S, Derwahl M, Meisinger C, Völzke H. Metformin inhibits goitrogenous effects of type 2 diabetes. Eur J Endocrinol. 2013 May 17;169(1):9-15. doi:10.1530/EJE-13-0101.

Wang C. The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. J Diabetes Res. 2013;2013:390534. doi:10.1155/2013/390534.

Knudsen N, Brix TH. Genetic and non-iodine-related factors in the aetiology of nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):495-506. doi:10.1016/j.beem.2014.02.005.




How to Cite

Tovkai, A. (2022). Iodine deficiency and prevalence of nodular goitre in Ukraine. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 18(4), 226–230.



Literature Review